Insider filing · HALO
Michael J. LaBarre
SVP, CHIEF TECHNICAL OFFICER
profile →
Halozyme Therapeutics, Inc.
HALO · Healthcare · 38 filings in 24 months
ticker →
Michael J. LaBarre sold $1.1M of Halozyme Therapeutics (HALO)
Executed Feb 25 2025, disclosed Feb 27 2025, 2 days later.
Value, as filed
$1.1M
18,700 sh across 2 lots
Executed
Feb 25 2025
the trade date, as filed
Disclosed
Feb 27 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MLMichael J. LaBarre (SVP, CHIEF TECHNICAL OFFICER) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $1.1M of HALO (18,700 sh across 2 lots, as filed), executed Feb 25 2025.
The name
HALOHealthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→